Chapters

Transcript

Video

From a medical cardiologist’s perspective, why is the mandate to lower LDL-C level so important for reducing CV risk? How low do recommend lowering the LDL-C level? Where do the PCSK9 inhibitors fit into the overall sequencing strategy?

From a medical cardiologist’s perspective, why is the mandate to lower LDL-C level so important for reducing CV risk? How low do recommend lowering the LDL-C level? Where do the PCSK9 inhibitors fit into the overall sequencing strategy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Samuel Goldhaber, MD

Samuel Goldhaber, MD

MD

Section Head, Vascular Medicine
Director, Thrombosis Research Group
Cardiovascular Medicine
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, MA USA